Apellis Pharmaceuticals (APLS) Q4 2023 Earnings

27FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-1.56
-1.28
-1.01
-0.73

Details

Expected EPS
-0.730739
Actual EPS
-0.73
Surprise EPS
0
Surprise Percent
+0.1%

Description

Apellis Pharmaceuticals (APLS) has reported earnings of -0.73 per share for Q4 2023.

0 Comments

Share your thoughts